Robert Hess is an angel investor focusing primarily on biochemistry, chemistry, drug discovery, medical devices and diagnostics. Previously, he was a patent attorney specializing in biotechnology patent prosecution. Robert has held both inhouse (Solazyme, BioMarin) and private practice (Sunstein Kann Murphy & Timbers, Leydig, Voit & Mayer) positions. Prior to becoming a patent attorney, he was a cofounder of BioTrove, a startup that invented highthroughput mass spectrometry and high-density miniturized PCR. He is named as an inventor on over a dozen patents. Robert holds B.S. in Biochemistry from Cornell University, a Ph.D. in Molecular Biophysics from University of Wisconsin - Madison, and a J.D. from Suffolk University Law School with a concentration in Intellectual Property.